TrialAntimicrobial agents and chemotherapy2018

Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China.

Qingfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.